| Detected | Trial | Change |
|---|---|---|
| 2026-08-15 | NCT06149286 A Trial to Find Out if Odronextamab Combined With Lenalidomide is Safe and Works Better… |
Primary endpoint(s) modified |
| 2026-08-15 | NCT06149286 A Trial to Find Out if Odronextamab Combined With Lenalidomide is Safe and Works Better… |
Enrollment increased: 470 -> 580 participants |
| 2026-08-15 | NCT06149286 A Trial to Find Out if Odronextamab Combined With Lenalidomide is Safe and Works Better… |
date change Primary completion pushed: 2029-01-23 -> 2031-04-30 |
| 2026-08-15 | NCT06149286 A Trial to Find Out if Odronextamab Combined With Lenalidomide is Safe and Works Better… |
date change Completion pushed: 2029-01-23 -> 2031-04-30 |
| 2026-08-14 | NCT07154290 A Study to Investigate Ubamatamab With and Without Marlotamig (REGN7075) in Adult… |
Trial sites expanded: 12 -> 15 locations |
| 2026-08-13 | NCT07675811 A Study to Evaluate the Efficacy and Safety of Fel d 1 Monoclonal Antibodies in Adult and… |
Recruitment opened |
| 2026-08-13 | NCT07675811 A Study to Evaluate the Efficacy and Safety of Fel d 1 Monoclonal Antibodies in Adult and… |
date change Primary completion pushed: 2027-10-16 -> 2029-05-31 |
| 2026-08-13 | NCT07675811 A Study to Evaluate the Efficacy and Safety of Fel d 1 Monoclonal Antibodies in Adult and… |
date change Completion pushed: 2028-06-30 -> 2029-09-20 |
| 2026-08-13 | NCT06787612 Investigation of Ubamatamab Combination Therapy in Adult Participants With… |
Enrollment increased: 220 -> 297 participants |
| 2026-08-13 | NCT06787612 Investigation of Ubamatamab Combination Therapy in Adult Participants With… |
Trial arms changed: 5 -> 6 |
| 2026-08-13 | NCT06787612 Investigation of Ubamatamab Combination Therapy in Adult Participants With… |
date change Primary completion moved earlier: 2028-10-30 -> 2028-06-30 |
| 2026-08-13 | NCT06787612 Investigation of Ubamatamab Combination Therapy in Adult Participants With… |
date change Completion moved earlier: 2028-10-30 -> 2028-06-30 |
| 2026-08-13 | NCT06693531 A U.S. Registry of Eosinophilic Esophagitis Pediatric, Adolescent and Adult Patients… |
Enrollment closed, study ongoing |
| 2026-08-11 | NCT06161441 A Trial to Learn if the Combination of Fianlimab, Cemiplimab, and Chemotherapy is Safe… |
date change Primary completion pushed: 2026-04-20 -> 2026-08-24 |
| 2026-08-08 | NCT05568459 A Trial That Evaluates Disease Characteristics in Hemophilia B Adult Male Participants… |
date change Primary completion pushed: 2026-05-21 -> 2026-08-21 |
| 2026-08-08 | NCT05568459 A Trial That Evaluates Disease Characteristics in Hemophilia B Adult Male Participants… |
date change Completion pushed: 2026-05-21 -> 2026-08-21 |
| 2026-08-07 | NCT06091865 A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it… |
Trial sites expanded: 168 -> 172 locations |
| 2026-08-07 | NCT06769698 A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab… |
Trial sites expanded: 27 -> 32 locations |
| 2026-08-06 | NCT07594106 REGN15505 (PSMAx4-1BB) Alone or in Combination With Cemiplimab or REGN4336 (PSMAxCD3) in… |
Recruitment opened |
| 2026-08-06 | NCT07594106 REGN15505 (PSMAx4-1BB) Alone or in Combination With Cemiplimab or REGN4336 (PSMAxCD3) in… |
Trial sites expanded: 0 -> 4 locations |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-08-12 | NCT07759167 Study of 3 Monoclonal Antibodies (REGN9933, REGN7508, and REGN9533) in Adult Participants… | Phase 1 | Not Yet Recruiting |
| 2026-08-07 | NCT07753148 Safety and Tolerability of REGN17235 in Adult Participants With Clonal Cytopenia of… | Phase 1 | Not Yet Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT07142343 | A Study to Test the Safety of Pozelimab in Pediatric Participants 1 to 5 Years of Age… | CHAPLE Disease | Recruiting |
| NCT07609940 | Adult Outpatient Linvoseltamab With Tocilizumab Prophylaxis to Mitigate the Risk of… | Relapsed/Refractory Multiple Myeloma (RRMM) | Recruiting |
| NCT07587658 | This After Market Study is Seeing if Dupilumab Plus Usual Standard of Care (SOC) is… | Chronic Obstructive Pulmonary Disease (COPD) | Not Yet Recruiting |
| NCT06572228 | Efficacy of Dupilumab Added to Medium Dose Inhaled Corticosteroid/Long-acting… | Asthma | Active, Not Recruiting |
| Phase 3 | |||
| NCT05730036 | A Trial to Learn How Well Linvoseltamab Works Compared to the Combination of Elotuzumab… | Relapsed Refractory Multiple Myeloma (RRMM) | Recruiting |
| NCT07220772 | A Study Evaluating Mibavademab Treatment of Obesity Due to Leptin (LEP) Gene Mutations in… | Monogenic Obesity | Recruiting |
| NCT07309432 | Study of Bet v1 Antibodies Effect on Eye Allergy Symptoms in Adolescents and Adults With… | Allergic Conjunctivitis | Recruiting |
| NCT07430956 | Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation… | Atrial Fibrillation (AF) | Recruiting |
| NCT07222761 | A Study to Compare Linvoseltamab Monotherapy and Linvoseltamab + Carfilzomib Combination… | Relapsed and/or Refractory Multiple Myeloma (RRMM) | Recruiting |
| NCT06585410 | Study of Intralesional Cemiplimab in Adult Patients With Early Stage Cutaneous Squamous… | Cutaneous Squamous Cell Carcinoma (CSCC) | Recruiting |
| NCT07015905 | REGN7508 Versus Apixaban and Enoxaparin for Thromboprophylaxis After Total Knee… | Venous Thromboembolism (VTE) | Recruiting |
| NCT07213778 | REGN7508 Versus Acetylsalicylic Acid (ASA) for Venous Thromboprophylaxis After Total Knee… | Symptomatic Venous Thromboembolism (VTE) | Recruiting |
| NCT07410117 | REGN7508 in Adult Participants for Prevention of Cancer-Associated Thrombosis | Cancer-Associated Thrombosis (CAT) | Recruiting |
| NCT06246916 | A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants… | Melanoma | Recruiting |
| NCT05744921 | A Study in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) to Evaluate How… | Paroxysmal Nocturnal Hemoglobinuria | Recruiting |
| NCT07318610 | Reducing Adverse Vascular Outcomes With Factor XI Inhibition in Adult Participants With… | Peripheral Artery Disease (PAD) | Recruiting |
| NCT07112378 | A Study of Dupilumab in Small Children With an Allergic Condition of the Esophagus (Food… | Eosinophilic Esophagitis (EoE) | Recruiting |
| NCT07154745 | A Study to Evaluate How Pozelimab + Cemdisiran Combination Therapy Works in Adult… | Paroxysmal Nocturnal Hemoglobinuria | Recruiting |
| NCT07220785 | Efficacy and Safety of Mibavademab in Adult and Pediatric Patients With Generalized… | Generalized Lipodystrophy | Recruiting |
| NCT06091865 | A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it… | Diffuse Large B-cell Lymphoma (DLBCL) | Recruiting |
| NCT07493304 | Treatment and Secondary Prevention of Venous Thromboembolism (VTE) in Adult Participants… | Venous Thromboembolism (VTE) | Recruiting |
| NCT07393282 | A Study to Compare Linvoseltamab and Daratumumab Treatment in High-Risk Smoldering… | High Risk Smoldering Multiple Myeloma (HR-SMM) | Recruiting |
| NCT06091254 | A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works… | Follicular Lymphoma (FL) | Recruiting |
| NCT06541704 | A Study Investigating Subcutaneously Administered Pozelimab in Combination With… | Age-related Macular Degeneration (AMD) | Recruiting |
| NCT07675811 | A Study to Evaluate the Efficacy and Safety of Fel d 1 Monoclonal Antibodies in Adult and… | Allergic Conjunctivitis | Recruiting |